|By Marketwired .||
|January 17, 2014 08:30 AM EST||
NEW YORK, NY -- (Marketwired) -- 01/17/14 -- Plandaí Biotechnology, Inc. (OTCQB: PLPL) may have just moved to the front of the line in the medical marijuana arena with this week's announcement that can only be described as a blockbuster partnership for the company's future. While other companies in the marijuana space wait on the industry to sort itself out, Plandaí is looking to familiarize the market with its products.
The good news for investors is that the company has chosen to partner with the well-known brand Diego Pellicer, Inc. and Diego Pellicer Worldwide Inc. to use the Diego Pellicer name for its cannabis extracts in medical and pharmaceutical marijuana applications. This deal will give Plandaí's cannabis extracts name recognition, and in these early stages in the arena of public medical marijuana companies that's big time.
Diego Pellicer has been the leading name in cannabis products for over a hundred years, a fact not lost on Plandaí CEO Roger Baylis-Duffield who said, "Being able to sell the Plandaí cannabinoid extracts under the Diego Pellicer name brings immediate name recognition and branding into the medicinal cannabis industry."
Jamen Shively is the co-founder of Diego Pellicer, Inc. as well as the great grandson of the company's namesake. Shively is a brand unto himself. The former Microsoft manager has been outspoken on his plans to build the first retail brand in the United States focused exclusively on legal premium marijuana. He's done just that and has discussed his ideas and plans for the marijuana industry on CNN, ABC News, FOX Business, CNBC, just to name a few.
Shively and Diego Pellicer can certainly help put Plandaí's cannabis products on the map, but it seems Plandaí has impressed Shively as well. "We couldn't be happier with our partnership with Plandaí. Their Phytofare technology appears to be years ahead of the competition as it relates to bioavailability and will help anchor the Diego brand as more states legalize cannabis for medical and/or recreational applications."
About Stock Market Media Group
SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.
This article is the opinion of SMMG and was written based upon publicly available information. Plandaí hasn't endorsed or compensated SMMG for this article.
Stock Market Media Group